1) mono-layer macromolecular polymers osmotic pump controlled-release tablets
单层高分子渗透泵控释片
1.
In this paper,lovastatin was selected as the model drug to prepare matrix sustained-release tablets (MST) and mono-layer macromolecular polymers osmotic pump controlled-release tablets (MOPT).
本文以难溶性药物洛伐他汀(Lovastatin)为模型药物，研究制备了洛伐他汀凝胶骨架缓释片和单层高分子渗透泵控释片，并对它们的释药行为及释药机理进行了探讨。
2) elementary osmotic pump controlled release tablets
单层渗透泵控释片
4) osmotic pump controlled-release tablets
渗透泵型控释片
1.
Ketoprofen osmotic pump controlled-release tablets were prepared.
制备了酮洛芬渗透泵型控释片,并进行了体外释放度和犬体内药动学试验。
2.
In this paper, gastrodin was selected as the model drug to prepare sustained-release tablets(ST), osmotic pump controlled-release tablets(OPT) and sustained-release pellets(SP).
本文以天麻素(Gastrodin)为模型药物，制备了天麻素缓释片、渗透泵型控释片，并利用流化床设备制备了天麻素缓释微丸。
5) osmotic pump controlled release tablets
渗透泵控释片
1.
Preparation of ambroxol hydrochloride osmotic pump controlled release tablets;
盐酸氨溴索渗透泵控释片的研制
2.
Objective To study pharmacokinetics of dogs in vivo of captopril osmotic pump controlled release tablets.
结论渗透泵控释片血药浓度平稳 ,可较长时间保持有效血药浓
3.
Objective:To study the in vitro release rate of ambroxol HCl osmotic pump controlled release tablets.
目的 :研究盐酸氨溴索渗透泵控释片的体外释放度。
6) osmotic pump tablet
渗透泵控释片
1.
In vitro and in vivo correlation of self-designed osmotic pump tablet of oxybutynin;
自制奥昔布宁渗透泵控释片的体内外相关性研究
补充资料：渗透泵
分子式：
CAS号：
性质：片剂外层包以半透膜，使水分透入。一侧由激光形成0.4mm直径的小孔，为释药口。片剂中心储以药物。透入水分使溶出，再由释药口流出。改变制剂的表面积、厚度及膜性质可调节单位时间内药物释放的速度。
CAS号：
性质：片剂外层包以半透膜，使水分透入。一侧由激光形成0.4mm直径的小孔，为释药口。片剂中心储以药物。透入水分使溶出，再由释药口流出。改变制剂的表面积、厚度及膜性质可调节单位时间内药物释放的速度。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条